Related Experiment Video
Updated: Apr 25, 2026

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
The M235T polymorphism in the angiotensinogen gene and atrial fibrillation: A meta-analysis
HuiXuan Wang1, Yi Teng2, Ke Wang2
1Laboratory Medicine Department, Kunming General Hospital of PLA, Kunming, China wanghuixuan2013@yahoo.com.
Objective:
The M235T polymorphism in the angiotensinogen gene has been reported to be associated with the development of atrial fibrillation (AF).However, results from observational studies are conflicting.
Methods:
PubMed, google scholar and China National Knowledge Infrastructure database(2000.1-2013.4) were searched for eligible articles; four separate studies with 2580 subjects on the relationship between M235T polymorphism and AF were analyzed by meta-analysis. The associations between M235T polymorphism and AF risk were estimated by pooled odds ratio (OR) and 95% confidence interval (CI) using a fixed or random-effects model.
Results:
There was a significant association between M235T polymorphism and AF. The pooled OR for the recessive model in the total population was 2.17 (95% CI: 1.39-3.38, I(2)=0%). In a subgroup analysis by nationality, the pooled OR for TT vs. MM genotype was 0.55 (95% CI: 0.32-0.95, I(2)=0%) and the pooled OR for the recessive model was 1.86 (95% CI: 1.08-3.20, I(2)=0%) in Asians.
Conclusions:
The current meta-analysis suggested that the M235T polymorphism in the angiotensinogen gene might be related to the increased risk of AF in Asians. Conclusive evidence on the effects of the variants in AF should be addressed in further studies.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

